160 related articles for article (PubMed ID: 2163462)
1. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
Naito T; Shiota H; Nitta K; Mimura Y
Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
Taylor JL; Casey MS; O'Brien WJ
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
[TBL] [Abstract][Full Text] [Related]
3. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA
Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929
[TBL] [Abstract][Full Text] [Related]
4. [Experimental studies of 9-(1, 3-dihydroxy-2-propoxymethyl)-guanine(DHPG) against herpes simplex virus].
Chen ZJ; Liu WG; Song JZ
Yao Xue Xue Bao; 1989; 24(5):331-4. PubMed ID: 2481939
[TBL] [Abstract][Full Text] [Related]
5. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
[TBL] [Abstract][Full Text] [Related]
7. Combined anti-herpes virus activity of nucleoside analogs and interferon.
Taylor JL; Punda-Polic V; O'Brien WJ
Curr Eye Res; 1991; 10 Suppl():205-11. PubMed ID: 1650669
[TBL] [Abstract][Full Text] [Related]
8. [In vitro sensitivity to antiviral agents of herpes simplex viruses isolated from patients with herpetic keratitis].
Mori Y; Inoue Y; Shimomura Y; Manabe R
Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):484-7. PubMed ID: 2171305
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
10. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the interaction of interferon with anti-herpetic agents].
Naito T
Nippon Ganka Gakkai Zasshi; 1988 Jul; 92(7):1177-84. PubMed ID: 2847515
[No Abstract] [Full Text] [Related]
13. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
Eppstein DA; Marsh YV
Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
[TBL] [Abstract][Full Text] [Related]
14. Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.
Pulliam L; Panitch HS; Baringer JR; Dix RD
Antimicrob Agents Chemother; 1986 Dec; 30(6):840-6. PubMed ID: 3028250
[TBL] [Abstract][Full Text] [Related]
15. [Combined activity of meliacin and foscarnet against different strains of herpes simplex virus type 1 using a three-dimensional model].
Barquero AA; Villamil SM
Rev Argent Microbiol; 1997; 29(1):32-7. PubMed ID: 9229723
[TBL] [Abstract][Full Text] [Related]
16. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
17. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiviral activity of Chamaecrista nictitans (Fabaceae) against herpes simplex virus: biological characterization of mechanisms of action.
Herrero Uribe L; Chaves Olarte E; Tamayo Castillo G
Rev Biol Trop; 2004 Sep; 52(3):807-16. PubMed ID: 17361573
[TBL] [Abstract][Full Text] [Related]
19. Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.
Scheck AC; Wigdahl B; De Clercq E; Rapp F
Antimicrob Agents Chemother; 1986 Apr; 29(4):589-93. PubMed ID: 3010847
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
